English
Back
Download
Log in to access Online Inquiry
Back to the Top

James Huang's appointment to Connect Biopharma's Board of Di...

James Huang's appointment to Connect Biopharma's Board of Directors is viewed positively, with his vast biotech and investment experience anticipated to offer unique insights and aid the company's pipeline progression.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
6393 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4821
    Followers
    0
    Following
    11K
    Visitors
    Follow
    Discussing
    Trump 2.0 Era: How will global markets evolve?
    🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.